All Essays

Senators Introduce Bipartisan Bill to Streamline Medical Device Approval

Senators Introduce Bipartisan Bill to Streamline Medical Device Approval

New bill would allow manufacturers of certain medical device to bypass elements of FDA’s existing process.

FTC Stalls Omnicare/PharMerica Merger

FTC Stalls Omnicare/PharMerica Merger

Antitrust complaint filed against pharmaceutical industry deal.

FHFA Publishes Proposed PACE Rule

FHFA Publishes Proposed PACE Rule

Proposed rule may make it harder for homeowners to obtain energy-saving loans.

An Incomplete Contraceptive Coverage Compromise

An Incomplete Contraceptive Coverage Compromise

Despite political assurances, nothing has changed legally in the contraceptive insurance controversy.

Week in Review

Week in Review

CA Proposition 8 struck down, $26 billion foreclosure settlement with banks, contraception mandate debate, and more.

EU Reveals New Strategy to Improve Online Privacy

EU Reveals New Strategy to Improve Online Privacy

Proposal would unify EU data protection laws and reduce business compliance costs.

Controversy Surrounds HHS Contraception Mandate

Controversy Surrounds HHS Contraception Mandate

President’s advisers signal willingness to “work with religious groups.”

FDA Submits User-Fee Recommendations to Congress

FDA Submits User-Fee Recommendations to Congress

Agency recommends statutory language for imposing user fees on biosimilar drug manufacturers.

YouTube Provides Modified Terms of Service to State Governments

YouTube Provides Modified Terms of Service to State Governments

Agreement addresses concern that YouTube’s standard terms of service violate state laws.

Commerce Department Responds to Concerns over Expansion of Internet Domain Names

Commerce Department Responds to Concerns over Expansion of Internet Domain Names

Public criticism prompts Commerce Department to address risks associated with domain name expansion.

Week in Review

Week in Review

Controversy over insurance coverage for contraception, changes to military family leave policies, highway fund woes and more.

FDA Warns Patients of Stem Cell Scams

FDA Warns Patients of Stem Cell Scams

The FDA cautions patients to undergo only approved stem cell treatments.